scholarly journals P15.02: Maternal serum levels of PlGF and sFlt‐1 in a low‐risk population of pregnant women in the third trimester in predicting fetal growth restriction

2019 ◽  
Vol 54 (S1) ◽  
pp. 202-202
Author(s):  
L. Roubalova ◽  
K. Langova ◽  
V. Kroutilova ◽  
V. Durdova ◽  
T. Kratochvilova ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Serum Levels ◽  
Maternal Serum ◽  
Growth Restriction ◽  
Low Risk ◽  
Third Trimester ◽  
Risk Population ◽  
The Third

scholarly journals P13.11: Maternal serum levels of PlGF and sFlt‐1 in a low‐risk population of pregnant women in the third trimester in predicting pre‐eclampsia

2019 ◽  
Vol 54 (S1) ◽  
pp. 198-198
Author(s):  
L. Roubalova ◽  
K. Langova ◽  
V. Kroutilova ◽  
V. Durdova ◽  
T. Kratochvilova ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Serum Levels ◽  
Maternal Serum ◽  
Low Risk ◽  
Third Trimester ◽  
Risk Population ◽  
The Third

scholarly journals OP08.08: Maternal serum levels of PlGF and sFlt‐1 in a low‐risk population of pregnant women in predicting delivery of an SGA newborn

2019 ◽  
Vol 54 (S1) ◽  
pp. 110-110
Author(s):  
L. Roubalova ◽  
K. Langova ◽  
V. Kroutilova ◽  
V. Durdova ◽  
T. Kratochvilova ◽  
...  
Keyword(s):  
Pregnant Women ◽  
Serum Levels ◽  
Maternal Serum ◽  
Low Risk ◽  
Risk Population

Prediction of fetal growth restriction using estimated fetal weightvsa combined screening model in the third trimester

2017 ◽  
Vol 50 (5) ◽  
pp. 603-611 ◽  
Author(s):  
J. Miranda ◽  
M. Rodriguez-Lopez ◽  
S. Triunfo ◽  
M. Sairanen ◽  
H. Kouru ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Growth Restriction ◽  
Third Trimester ◽  
The Third ◽  
Screening Model

scholarly journals Macrophage Migration Inhibitory Factor in Fetoplacental Tissues from Preeclamptic Pregnancies with or without Fetal Growth Restriction

2012 ◽  
Vol 2012 ◽  
pp. 1-9 ◽  
Author(s):  
Simona Cardaropoli ◽  
Luana Paulesu ◽  
Roberta Romagnoli ◽  
Francesca Ietta ◽  
Daniela Marzioni ◽  
...  
Keyword(s):  
Fetal Growth ◽  
Migration Inhibitory Factor ◽  
Fetal Growth Restriction ◽  
Macrophage Migration Inhibitory Factor ◽  
Serum Levels ◽  
Maternal Serum ◽  
Growth Restriction ◽  
Inhibitory Factor ◽  
Macrophage Migration ◽  
The Difference

The proinflammatory cytokine MIF (macrophage migration inhibitory factor) is involved in physiological and pathological processes in pregnancy. MIF maternal serum levels are increased in preeclampsia (PE). We hypothesize that pregnancy tissues are the source of MIF overexpression in PE. MIF protein was studied in maternal sera, placental tissues, fetal membranes, and umbilical cord of 8 control and 20 PE pregnancies: 10 with normal fetal growth (PE-AGA) and 10 with fetal growth restriction (PE-FGR). MIF levels were significantly higher in PE-AGA membranes than in controls and PE-FGR. In PE-FGR, MIF cord concentrations were higher than in PE-AGA while MIF placental levels were lower than in controls. MIF maternal serum levels were higher in PE, compared to controls, and the difference was mainly due to PE-FGR samples. These data support MIF involvement in PE pathogenesis and suggest that different pregnancy tissues contribute to MIF production in PE with and without fetoplacental compromise.

First-Trimester Maternal Serum Levels of Placenta Growth Factor as Predictor of Preeclampsia and Fetal Growth Restriction

2001 ◽  
Vol 98 (4) ◽  
pp. 608-611 ◽  
Author(s):  
Charas Y. T. Ong ◽  
Adolfo W. Liao ◽  
Ana M. Cacho ◽  
Kevin Spencer ◽  
Kypros H. Nicolaides
Keyword(s):  
Growth Factor ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Serum Levels ◽  
First Trimester ◽  
Maternal Serum ◽  
Growth Restriction ◽  
Placenta Growth Factor

FETAL GROWTH RESTRICTION WITH EARLY AND LATE MANIFESTATION, PROGNOSTIC MARKERS

2020 ◽  
pp. 27-30
Author(s):  
Yakubova D.I.
Keyword(s):  
Risk Factors ◽  
Pregnant Women ◽  
Fetal Growth ◽  
Fetal Growth Restriction ◽  
Prenatal Screening ◽  
Prognostic Markers ◽  
Growth Restriction ◽  
Late Manifestation ◽  
Late Form ◽  
Early Manifestation

Objective of the study: Comprehensive assessment of risk factors, the implementation of which leads to FGR with early and late manifestation. To evaluate the results of the first prenatal screening: PAPP-A, B-hCG, made at 11-13 weeks. Materials and Methods: A retrospective study included 110 pregnant women. There were 48 pregnant women with early manifestation of fetal growth restriction, 62 pregnant women with late manifestation among them. Results of the study: The risk factors for the formation of the FGR are established. Statistically significant differences in the indicators between groups were not established in the analyses of structures of extragenital pathology. According to I prenatal screening, there were no statistical differences in levels (PAPP-A, b-hCG) in the early and late form of FGR.

Sign in / Sign up

Export Citation Format

Share Document